African American men are particularly susceptible to prostate cancer incidence, but genetic factors mediating prostate cancer risk in African American men remain poorly defined. To search for genetic contributors to prostate cancer occurrence in African American men, Zhang and colleagues performed whole exome sequencing using blood samples from men from 20 families affected by hereditary prostate cancer. Sequencing revealed a rare non-synonymous ADPRHL1 variant, c.A233T, encoding a p.D78V amino acid conversion, that was present in men affected by prostate cancer in four of the families but not present in 170 unrelated healthy African American men. Functional studies demonstrated that the A233T variant increases prostate cancer cell growth and induces PARP activation. A233T variant-mediated PARP activation renders prostate cancer cells resistant to DNA damaging agents but susceptible to PARP inhibitor olaparib. The authors also found that ADPRHL1 abundance decreases during prostate cancer progression, suggesting A233T is a loss-of-function variant. Altogether, this...
Skip Nav Destination
Highlights| December 02 2022
Selected Articles from This Issue
Online Issn: 1557-3125
Print Issn: 1541-7786
©2022 American Association for Cancer Research
American Association for Cancer Research
Mol Cancer Res (2022) 20 (12): 1709.
A commentary has been published: The C-terminus of Gain-of-Function Mutant p53 R273H Is Required for Association with PARP1 and Poly-ADP-Ribose
A commentary has been published: A Recurrent ADPRHL1 Germline Mutation Activates PARP1 and Confers Prostate Cancer Risk in African American Families
A commentary has been published: Regulation of Cyclin D1 Degradation by Ubiquitin-Specific Protease 27X Is Critical for Cancer Cell Proliferation and Tumor Growth
A commentary has been published: Raptinal Induces Gasdermin E–Dependent Pyroptosis in Naïve and Therapy-Resistant Melanoma
- Views Icon Views
- Share Icon Share
- Search Site
Article Versions Icon
- Version of Record December 2 2022
Selected Articles from This Issue. Mol Cancer Res 1 December 2022; 20 (12): 1709. https://doi.org/10.1158/1541-7786.MCR-20-12-HI
Download citation file:
Don't already have an account? Register
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your InstitutionSign in via your Institution